We use intraday and daily data to examine the impact of cross-sectional return dispersion on volatility forecasting in the Chinese equity market. We adopt the GARCH, GJR-GARCH, and HAR models and, by augmenting them with return dispersion measures, provide empirical evidence that the return dispersion exhibits substantial information in describing the volatility dynamics by generating significantly lower forecasting errors at market and industry levels.Furthermore, the information content of the return dispersion tends to offer economic gain to a mean-variance utility investor. The findings are robust with respect to alternative volatility proxies, subsample analysis, and alternative market-wide stock indices. JEL code: G11, G17.
In this paper, we study the predictive performance of two kinds of volatility estimators: the realized volatility (RV) type and duration‐based ones. This is motivated by the theoretical and empirical support for these distinct estimators. We use intraday data for 218 component stocks of the CSI 300 index in the Chinese equity market from 2010–2019 and perform in‐ and out‐of‐sample 1‐, 5‐, and 22‐day ahead volatility forecasts from combinations of volatility models and these estimators. We show that, although empirically more efficient with the US data, the duration‐based estimators fail to compete statistically, or in terms of economic value, with RV‐type ones in the Chinese market. We perform a comprehensive set of simulations to rationalize these results and show that duration‐based estimators underperform as they cannot handle the occasional heightened level of volatility in the Chinese market.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.